TOX3 and cancer: Given the results above, we assumed that WDR5 tri-methylates H3K4 at ABCG2 promoter to further recruit TOX3 resulting in the up-regulation of ABCG2 transcription and ultimately in the development of cancer stem-like traits and drug resistance.